Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-14.22	166.88	194.54
Graham Fair Price	4.02	59.06	56.78
PEG	183.38	8.62	3.04
Price/Book	-6.55	-42.32	-39.72
Price/Cash Flow	111.68	505.29	238.70
Prices/Earnings	0.73	59.96	59.52
Price/Sales	-4.88	71.76	75.45
Price/FCF	111.68	505.29	238.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	2.23	0.80	0.78
Operating Margin	13.37	0.45	0.40
ROA	0.31	0.08	0.08
ROE	-0.17	-0.18	-5.77
ROIC	0.11	0.11	-0.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.05	0.05	-18.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.09	0.29	231.95
EPS QOQ	0.20	0.07	-64.45
FCF QOQ	-0.26	-0.49	-89.06
Revenue QOQ	-0.02	0.14	587.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	86.57	97.31	12.41
Inventory Turnover	0.00	87221000.00	100.00
Debt/Capitalization	1.57	1.56	-1.16
Quick Ratio	1.13	1.92	69.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-29.31	-29.64	-1.14
Cash	4.99	5.47	9.64
Capex	-0.05	-0.38	-590.75
Free Cash Flow	4.88	2.48	-49.09
Revenue	15.43	17.48	13.29
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.31	2.04	55.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.61	9.80	-15.52
Naive Interpretation	Member

06 - Financial Health · Bad

Rating